The novel therapy of this peptide represents a major development in the care of type 2 diabetes. Different to existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide886982.bligblogging.com/42806119/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment